<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39456071</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Impact of low dose inhaled nitric oxide treatment in spontaneously breathing and intubated COVID-19 patients: a retrospective propensity-matched study.</ArticleTitle><Pagination><StartPage>344</StartPage><MedlinePgn>344</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">344</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-024-05093-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The benefit of Inhaled nitric oxide (iNO) therapy in the setting of COVID-19-related ARDS is obscure. We performed a multicenter retrospective study to evaluate the impact of iNO on patients with COVID-19 who require respiratory support.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective multicenter study included COVID-19 patients enrolled in the SCCM VIRUS COVID-19 registry who were admitted to different Mayo Clinic sites between March 2020 and June 2022 and required high-flow nasal cannula (HFNC), non-invasive ventilation (NIV), or invasive mechanical ventilation (IMV). Patients were included in the 'spontaneously breathing' group if they remained non-intubated or were initiated on an HFNC (± NIV) before intubation. Patients who got intubated without prior use of an HFNC (± NIV) were included in the 'intubated group.' They were further divided into categories based on their iNO usage. Propensity score matching (PSM) and inverse propensity of treatment weighting (IPTW) were performed to examine outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 2767 patients included in our analysis, 1879 belonged to spontaneously breathing (153 received iNO), and 888 belonged to the intubated group (193 received iNO). There was a consistent improvement in FiO2 requirement, P/F ratio, and respiratory rate within 48 h of iNO use among both spontaneously breathing and intubated groups. However, there was no significant difference in intubation risk with iNO use among spontaneously breathing patients (PSM OR 1.08, CI 0.71-1.65; IPTW OR 1.10, CI 0.90-1.33). In a time-to-event analysis using Cox proportional hazard model, spontaneously breathing patients initiated on iNO had a lower hazard ratio of in-hospital mortality (PSM HR 0.49, CI 0.32-0.75, IPTW HR 0.40, 95% CI 0.26-0.62) but intubated patients did not (PSM HR: 0.90; CI 0.66-1.24, IPTW HR 0.98, 95% CI 0.73-1.31). iNO use was associated with longer in-hospital stays, ICU stays, ventilation duration, and a higher incidence of creatinine rise.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This retrospective propensity-score matched study showed that spontaneously breathing COVID-19 patients on HFNC/ NIV support had a decreased in-hospital mortality risk with iNO use in a time-to-event analysis. Both intubated and spontaneously breathing patients had improvement in oxygenation parameters with iNO therapy but were associated with longer in-hospital stays, ICU stays, ventilation duration, and higher incidence of creatinine rise.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Isha</LastName><ForeName>Shahin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balasubramanian</LastName><ForeName>Prasanth</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanson</LastName><ForeName>Abby J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonna</LastName><ForeName>Sadhana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raavi</LastName><ForeName>Lekhya</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khadka</LastName><ForeName>Subekshya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasudhar</LastName><ForeName>Ananya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinclair De Frias</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mayo Clinic Alix School of Medicine, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balavenkataraman</LastName><ForeName>Arvind</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tekin</LastName><ForeName>Aysun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bansal</LastName><ForeName>Vikas</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Swetha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caples</LastName><ForeName>Sean M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Syed Anjum</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic Health System, Mankato, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Nitesh K</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic Health System, Mankato, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LaNou</LastName><ForeName>Abigail T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Emergency Medicine and Critical Care, Mayo Clinic Health System, Eau Claire, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kashyap</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cartin-Ceba</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milian</LastName><ForeName>Ricardo Diaz</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venegas</LastName><ForeName>Carla P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>Anna B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhattacharyya</LastName><ForeName>Anirban</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiley</LastName><ForeName>Sean P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinones</LastName><ForeName>Quintin J</ForeName><Initials>QJ</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Neal M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guru</LastName><ForeName>Pramod K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno Franco</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanghavi</LastName><ForeName>Devang K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA. sanghavi.devang@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="Y">Nitric Oxide</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="Y">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ARDS</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">HFNC</Keyword><Keyword MajorTopicYN="N">Inhaled nitric oxide</Keyword><Keyword MajorTopicYN="N">Non-invasive ventilation</Keyword></KeywordList><CoiStatement>Rahul Kashyap: Grant and contracts—Gordan and Betty Moore Foundation, Jenssen and Jenssen LLC; all payments made to the institution. No conflict of interest related to this manuscript. Rest other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39456071</ArticleId><ArticleId IdType="doi">10.1186/s13054-024-05093-w</ArticleId><ArticleId IdType="pii">10.1186/s13054-024-05093-w</ArticleId><ArticleId IdType="pmc">PMC11515277</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818–24.</Citation><ArticleIdList><ArticleId IdType="pubmed">7509706</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamo T, Tasaka S, Suzuki T, Asakura T, Suzuki S, Yagi K, et al. Prognostic values of the Berlin definition criteria, blood lactate level, and fibroproliferative changes on high-resolution computed tomography in ARDS patients. BMC Pulm Med. 2019;19(1):37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6371514</ArticleId><ArticleId IdType="pubmed">30744598</ArticleId></ArticleIdList></Reference><Reference><Citation>ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–33.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993;328(6):399–405.</Citation><ArticleIdList><ArticleId IdType="pubmed">8357359</ArticleId></ArticleIdList></Reference><Reference><Citation>Creagh-Brown BC, Griffiths MJD, Evans TW. Bench-to-bedside review: Inhaled nitric oxide therapy in adults. Crit Care Lond Engl. 2009;13(3):221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717403</ArticleId><ArticleId IdType="pubmed">19519946</ArticleId></ArticleIdList></Reference><Reference><Citation>Gries A, Bode C, Peter K, Herr A, Böhrer H, Motsch J, et al. Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo. Circulation. 1998;97(15):1481–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9576429</ArticleId></ArticleIdList></Reference><Reference><Citation>Gries A, Herr A, Motsch J, Holzmann A, Weimann J, Taut F, et al. Randomized, placebo-controlled, blinded and cross-matched study on the antiplatelet effect of inhaled nitric oxide in healthy volunteers. Thromb Haemost. 2000;83(2):309–15.</Citation><ArticleIdList><ArticleId IdType="pubmed">10739391</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt JL, Bronicki RA, Anas N. Role of inhaled nitric oxide in the management of severe acute respiratory distress syndrome. Front Pediatr. 2016;4:74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4970488</ArticleId><ArticleId IdType="pubmed">27532031</ArticleId></ArticleIdList></Reference><Reference><Citation>Karam O, Gebistorf F, Wetterslev J, Afshari A. The effect of inhaled nitric oxide in acute respiratory distress syndrome in children and adults: a cochrane systematic review with trial sequential analysis. Anaesthesia. 2017;72(1):106–17.</Citation><ArticleIdList><ArticleId IdType="pubmed">27762438</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhikari NKJ, Burns KEA, Friedrich JO, Granton JT, Cook DJ, Meade MO. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ. 2007;334(7597):779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1852043</ArticleId><ArticleId IdType="pubmed">17383982</ArticleId></ArticleIdList></Reference><Reference><Citation>MekontsoDessap A, Papazian L, Schaller M, Nseir S, Megarbane B, Haudebourg L, et al. Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes. Ann Intensive Care. 2023;13(1):57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10299982</ArticleId><ArticleId IdType="pubmed">37368036</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebistorf F, Karam O, Wetterslev J, Afshari A. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev. 2016;2016(6):CD002787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464789</ArticleId><ArticleId IdType="pubmed">27347773</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim ZJ, Subramaniam A, Ponnapa Reddy M, Blecher G, Kadam U, Afroz A, et al. Case fatality rates for patients with COVID-19 requiring invasive mechanical ventilation. A Meta-analysis. Am J Respir Crit Care Med. 2021;203(1):54–66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7781141</ArticleId><ArticleId IdType="pubmed">33119402</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira E, Parikh A, Lopez-Ruiz A, Carrilo M, Goldberg J, Cearras M, et al. ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida. PLoS ONE. 2021;16(3): e0249038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7993561</ArticleId><ArticleId IdType="pubmed">33765049</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Lu X, Li Y, Chen H, Chen T, Su N, et al. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med. 2020;201(11):1430–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7258632</ArticleId><ArticleId IdType="pubmed">32267160</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslan A, Aslan C, Zolbanin NM, Jafari R. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management. Pneumonia Nathan Qld. 2021;13(1):14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8647516</ArticleId><ArticleId IdType="pubmed">34872623</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854–87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7101866</ArticleId><ArticleId IdType="pubmed">32222812</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthay MA, Aldrich JM, Gotts JE. Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir Med. 2020;8(5):433–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118607</ArticleId><ArticleId IdType="pubmed">32203709</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng WX, Yang Y, Wen J, Liu YX, Liu L, Feng C. Implication of inhaled nitric oxide for the treatment of critically ill COVID-19 patients with pulmonary hypertension. ESC Heart Fail. 2021;8(1):714–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753827</ArticleId><ArticleId IdType="pubmed">33205620</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi J, Murata I. Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome. Ann Intensive Care. 2020;10(1):61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7238394</ArticleId><ArticleId IdType="pubmed">32436029</ArticleId></ArticleIdList></Reference><Reference><Citation>Åkerström S, Mousavi-Jazi M, Klingström J, Leijon M, Lundkvist Å, Mirazimi A. Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J Virol. 2005;79(3):1966–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC544093</ArticleId><ArticleId IdType="pubmed">15650225</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor RW, Zimmerman JL, Dellinger RP, Straube RC, Criner GJ, Davis K, et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA. 2004;291(13):1603–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15069048</ArticleId></ArticleIdList></Reference><Reference><Citation>Abman SH, Fox NR, Malik MI, Kelkar SS, Corman SL, Rege S, et al. Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome. Drugs Context. 2022;11:2022–1–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9007062</ArticleId><ArticleId IdType="pubmed">35462641</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandel A, Patolia S, Ahmad K, Aryal S, Brown AW, Sahjwani D, et al. Inhaled nitric oxide via high-flow nasal cannula in patients with acute respiratory failure related to COVID-19. Clin Med Insights Circ Respir Pulm Med. 2021;15:11795484211047064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8485265</ArticleId><ArticleId IdType="pubmed">34602831</ArticleId></ArticleIdList></Reference><Reference><Citation>SafaeeFakhr B, Di Fenza R, Gianni S, Wiegand SB, Miyazaki Y, Araujo Morais CC, et al. Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumonia. Nitric Oxide Biol Chem. 2021;1(116):7–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8361002</ArticleId><ArticleId IdType="pubmed">34400339</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi G, Pozzi M, Mongodi S, Dammassa V, Romito G, Mojoli F. Inhaled nitric oxide in patients admitted to intensive care unit with COVID-19 pneumonia. Crit Care Lond Engl. 2020;24(1):508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429937</ArticleId><ArticleId IdType="pubmed">32807220</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziehr DR, Alladina J, Wolf ME, Brait KL, Malhotra A, La Vita C, et al. Respiratory physiology of prone positioning with and without inhaled nitric oxide across the coronavirus disease 2019 acute respiratory distress syndrome severity spectrum. Crit Care Explor. 2021;3(6): e0471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8208401</ArticleId><ArticleId IdType="pubmed">34151287</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Fenza R, Shetty NS, Gianni S, Parcha V, Giammatteo V, SafaeeFakhr B, et al. High-dose inhaled nitric oxide in acute hypoxemic respiratory failure due to COVID-19: a multicenter phase II Trial. Am J Respir Crit Care Med. 2023;208(12):1293–304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10765403</ArticleId><ArticleId IdType="pubmed">37774011</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani JS, Aldhahir AM, Al Ghamdi SS, AlBahrani S, AlDraiwiesh IA, Alqarni AA, et al. Inhaled nitric oxide for clinical management of COVID-19: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(19):12803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9566710</ArticleId><ArticleId IdType="pubmed">36232100</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkey AJ, Sheldrick RC, Kashyap R, Kumar VK, Boman K, Bolesta S, et al. Guiding principles for the conduct of observational critical care research for coronavirus disease 2019 pandemics and beyond: the society of critical care medicine discovery viral infection and respiratory illness universal study registry. Crit Care Med. 2020;48(11):e1038–44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540620</ArticleId><ArticleId IdType="pubmed">32932348</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkey AJ, Sheldrick RC, Kashyap R, Kumar VK, Boman K, Bolesta S, et al. Guiding principles for the conduct of observational critical care research for coronavirus disease 2019 pandemics and beyond: the society of critical care medicine discovery viral infection and respiratory illness universal study registry. Crit Care Med. 2020;48(11):e1038–44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540620</ArticleId><ArticleId IdType="pubmed">32932348</ArticleId></ArticleIdList></Reference><Reference><Citation>Domecq JP, Lal A, Sheldrick CR, Kumar VK, Boman K, Bolesta S, et al. Outcomes of patients with coronavirus disease 2019 receiving organ support therapies: the international viral infection and respiratory illness universal study registry. Crit Care Med. 2021;49(3):437–48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9520995</ArticleId><ArticleId IdType="pubmed">33555777</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarrarapu SNS, Bansal P, Abia-Trujillo D, Cusick A, Melody M, Moktan V, et al. V.I.T.A.M. in COVID 19: A Systematic Approach to a Global Pandemic. Clin Med Insights Circ Respir Pulm Med. 2021;15:11795484211047432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8493324</ArticleId><ArticleId IdType="pubmed">34629922</ArticleId></ArticleIdList></Reference><Reference><Citation>Section 2: AKI definition. Kidney Int Suppl. 2012;2(1):19–36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4089595</ArticleId><ArticleId IdType="pubmed">25018918</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho DE, Imai K, King G, Stuart EA. MatchIt : Nonparametric Preprocessing for Parametric Causal Inference. J Stat Softw [Internet]. 2011 [cited 2024 May 4];42(8). http://www.jstatsoft.org/v42/i08/</Citation></Reference><Reference><Citation>Seppala LJ, van de Loo B, Schut M, van Schoor NM, Stricker BH, Kenny RA, et al. A propensity score matched approach to assess the associations of commonly prescribed medications with fall risk in a large harmonized cohort of older ambulatory persons. Drugs Aging. 2021;38(9):797–805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8419131</ArticleId><ArticleId IdType="pubmed">34224104</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med. 2014;33(7):1242–58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285179</ArticleId><ArticleId IdType="pubmed">24122911</ArticleId></ArticleIdList></Reference><Reference><Citation>Longobardo A, Montanari C, Shulman R, Benhalim S, Singer M, Arulkumaran N. Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome. Br J Anaesth. 2021;126(1):e44–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556790</ArticleId><ArticleId IdType="pubmed">33138964</ArticleId></ArticleIdList></Reference><Reference><Citation>Grieco DL, Maggiore SM, Roca O, Spinelli E, Patel BK, Thille AW, et al. Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS. Intensive Care Med. 2021;47(8):851–66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8261815</ArticleId><ArticleId IdType="pubmed">34232336</ArticleId></ArticleIdList></Reference><Reference><Citation>Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med. 2017;195(4):438–42.</Citation><ArticleIdList><ArticleId IdType="pubmed">27626833</ArticleId></ArticleIdList></Reference><Reference><Citation>Grotberg JC, Kraft BD. Timing of intubation in COVID-19: when it is too early and when it is too late. Crit Care Explor. 2023;5(2): e0863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9928829</ArticleId><ArticleId IdType="pubmed">36817964</ArticleId></ArticleIdList></Reference><Reference><Citation>Villarreal-Fernandez E, Patel R, Golamari R, Khalid M, DeWaters A, Haouzi P. A plea for avoiding systematic intubation in severely hypoxemic patients with COVID-19-associated respiratory failure. Crit Care Lond Engl. 2020;24(1):337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7291186</ArticleId><ArticleId IdType="pubmed">32532318</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. 2020; https://apps.who.int/iris/handle/10665/331446</Citation></Reference><Reference><Citation>Cheung JCH, Ho LT, Cheng JV, Cham EYK, Lam KN. Staff safety during emergency airway management for COVID-19 in Hong Kong. Lancet Respir Med. 2020;8(4): e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128208</ArticleId><ArticleId IdType="pubmed">32105633</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA. 2020;323(22):2329–30.</Citation><ArticleIdList><ArticleId IdType="pubmed">32329799</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CA, Mosier JM, Carlson JN, Gibbs MA. Pragmatic recommendations for intubating critically ill patients with suspected COVID-19. J Am Coll Emerg Physicians Open. 2020;1(2):80–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228350</ArticleId><ArticleId IdType="pubmed">32427182</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty AB, Mulholland RH, Lone NI, Cheyne CP, De Angelis D, Diaz-Ordaz K, et al. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. Lancet Respir Med. 2021;9(7):773–85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8121531</ArticleId><ArticleId IdType="pubmed">34000238</ArticleId></ArticleIdList></Reference><Reference><Citation>Parish AJ, West JR, Caputo ND, Janus TM, Yuan D, Zhang J, et al. Early intubation and increased coronavirus disease 2019 mortality: A propensity score-matched retrospective cohort study. Crit Care Explor. 2021;3(6): e0452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8208412</ArticleId><ArticleId IdType="pubmed">34151281</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins GD, Ji C, Connolly BA, Couper K, Lall R, Baillie JK, et al. Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: The RECOVERY-RS randomized clinical trial. JAMA. 2022;327(6):546–58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8787685</ArticleId><ArticleId IdType="pubmed">35072713</ArticleId></ArticleIdList></Reference><Reference><Citation>Camous L, Pommier JD, Martino F, Tressieres B, Demoule A, Valette M. Very late intubation in COVID-19 patients: a forgotten prognosis factor? Crit Care Lond Engl. 2022;26(1):89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8976275</ArticleId><ArticleId IdType="pubmed">35366941</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannidis C, Hentschker C, Westhoff M, Weber-Carstens S, Janssens U, Kluge S, et al. Observational study of changes in utilization and outcomes in mechanical ventilation in COVID-19. PLoS ONE. 2022;17(1): e0262315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8759661</ArticleId><ArticleId IdType="pubmed">35030205</ArticleId></ArticleIdList></Reference><Reference><Citation>González J, Benítez ID, de Gonzalo-Calvo D, Torres G, de Batlle J, Gómez S, et al. Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study. Crit Care Lond Engl. 2022;26(1):18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8744383</ArticleId><ArticleId IdType="pubmed">35012662</ArticleId></ArticleIdList></Reference><Reference><Citation>Polok K, Fronczek J, Artigas A, Flaatten H, Guidet B, De Lange DW, et al. Noninvasive ventilation in COVID-19 patients aged ≥ 70 years-a prospective multicentre cohort study. Crit Care Lond Engl. 2022;26(1):224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9305028</ArticleId><ArticleId IdType="pubmed">35869557</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman JB, Leibner ES, Tandon P, Egorova NN, Bassily-Marcus A, Kohli-Seth R, et al. Timing of intubation and in-hospital mortality in patients with coronavirus disease 2019. Crit Care Explor. 2020;2(10): e0254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7587418</ArticleId><ArticleId IdType="pubmed">33134945</ArticleId></ArticleIdList></Reference><Reference><Citation>Vera M, Kattan E, Born P, Rivas E, Amthauer M, Nesvadba A, et al. Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection. J Crit Care. 2021;65:164–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8216652</ArticleId><ArticleId IdType="pubmed">34166852</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu W, Guo S, Yang F, Liu B, Zhang Z, Liu X, et al. Association between ARDS etiology and risk of noninvasive ventilation failure. Ann Am Thorac Soc. 2022;19(2):255–63.</Citation><ArticleIdList><ArticleId IdType="pubmed">34288830</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernández G, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med. 2019;199(11):1368–76.</Citation><ArticleIdList><ArticleId IdType="pubmed">30576221</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca O, Messika J, Caralt B, García-de-Acilu M, Sztrymf B, Ricard JD, et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index. J Crit Care. 2016;35:200–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">27481760</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhikari NKJ, Dellinger RP, Lundin S, Payen D, Vallet B, Gerlach H, et al. Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis*. Crit Care Med. 2014;42(2):404–12.</Citation><ArticleIdList><ArticleId IdType="pubmed">24132038</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh R, Wilson C, Weinberg J, Gavin D, Murphy J, Reardon CC. Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients. Ther Adv Respir Dis. 2020;14:175346662093351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7298422</ArticleId><ArticleId IdType="pubmed">32539647</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari M, Santini A, Protti A, Andreis DT, Iapichino G, Castellani G, et al. Inhaled nitric oxide in mechanically ventilated patients with COVID-19. J Crit Care. 2020;60:159–60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417286</ArticleId><ArticleId IdType="pubmed">32814271</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Sulaiman K, Korayem GB, Altebainawi AF, Al Harbi S, Alissa A, Alharthi A, et al. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study. Crit Care. 2022;26(1):304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9527729</ArticleId><ArticleId IdType="pubmed">36192801</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Cong X, Miao M, Yang Y, Zhang J. Inhaled nitric oxide and acute kidney injury risk: a meta-analysis of randomized controlled trials. Ren Fail. 2021;43(1):281–90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850389</ArticleId><ArticleId IdType="pubmed">33494652</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapol WM, Hurford WE. Inhaled Nitric Oxide in Adult Respiratory Distress Syndrome and Other Lung Diseases. In: Advances in Pharmacology [Internet]. Elsevier; 1994 [cited 2024 Jul 6]. p. 513–30. https://linkinghub.elsevier.com/retrieve/pii/S1054358908606390</Citation><ArticleIdList><ArticleId IdType="pubmed">7873435</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach H, Keh D, Semmerow A, Busch T, Lewandowski K, Pappert DM, et al. Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study. Am J Respir Crit Care Med. 2003;167(7):1008–15.</Citation><ArticleIdList><ArticleId IdType="pubmed">12663340</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>